ALURD (Allurion Technologies) ROIC %: -45.55% (As of Mar. 2026)


ALURD Allurion Technologies Inc ALURD
16 GF Score
Price $5.91
GF Value $10.66
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Allurion Technologies ROIC %?

Allurion Technologies ALURD -2.11% 16 ROIC % is -45.55% as of Mar. 2026. GuruFocus rates ALURD with a GF Score™ of 16/100 and a GF Value™ of $10.66 (Possible Value Trap). The stock has 4 warning signs investors should review.

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Allurion Technologies's annualized return on invested capital (ROIC %) for the quarter that ended in Mar. 2026 was -45.55%.

As of today (2026-06-24), Allurion Technologies's WACC % is 6.61%. Allurion Technologies's ROIC % is -155.42% (calculated using TTM income statement data). Allurion Technologies earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Allurion Technologies  (OTCPK:ALURD) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Allurion Technologies's WACC % is 6.61%. Allurion Technologies's ROIC % is -155.42% (calculated using TTM income statement data). Allurion Technologies earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Allurion Technologies ROIC % Related Terms


Allurion Technologies ROIC % Historical Data

* Premium members only.

The historical data trend for Allurion Technologies's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Allurion Technologies ROIC % Chart

Allurion Technologies Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
ROIC %
-43.72 -67.89 -138.93 -180.22 -149.78

Allurion Technologies Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -383.95 -392.74 -617.90 -128.87 -45.55

ALURD vs ALRTF, VVOS, SINT: ROIC % Comparison

For the Medical Devices subindustry, Allurion Technologies's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Allurion Technologies ROIC % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Allurion Technologies's ROIC % distribution charts can be found below:

* The bar in red indicates where Allurion Technologies's ROIC % falls into.


ALURD
16GF Score
Allurion Technologies Inc ALURD
ROIC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Allurion Technologies ROIC % Calculation

Allurion Technologies's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Dec. 2025 is calculated as:

ROIC % (A: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2024 ) + Invested Capital (A: Dec. 2025 ))/ count )
=-30.157 * ( 1 - 0% )/( (7.572 + 32.696)/ 2 )
=-30.157/20.134
=-149.78 %

where

Allurion Technologies's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Mar. 2026 is calculated as:

ROIC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-14.924 * ( 1 - 0% )/( (32.696 + 32.834)/ 2 )
=-14.924/32.765
=-45.55 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROIC % →
What does a ROIC % of -45.55% mean?
Allurion Technologies (ALURD) has a ROIC % of -45.55% as of Mar. 2026. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on Allurion Technologies and its competitors.
Is Allurion Technologies' ROIC % too high?
Allurion Technologies' current ROIC % is -45.55%. Overall, Allurion Technologies has a GF Score™ of 16/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Allurion Technologies' ROIC % compare to ALRTF and VVOS?
Allurion Technologies' ROIC % of -45.55% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROIC % is 1.27. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROIC % for a Medical Devices & Instruments company?
The median ROIC % among Medical Devices & Instruments companies is 1.27, based on 847 companies in the industry. Companies in the top quartile (top 25%) have a ROIC % significantly above this median, while those in the bottom quartile fall well below. However, ROIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROIC % mean?
A high ROIC % can signal that a stock is expensive relative to its fundamentals. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on Allurion Technologies and its competitors. For the Medical Devices & Instruments industry, the median ROIC % is 1.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Allurion Technologies's current ROIC % is -45.55%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Allurion Technologies stock overvalued right now?
Based on GuruFocus' analysis, Allurion Technologies (ALURD) is currently considered Possible Value Trap. The stock's GF Value™ is $10.66, compared to a current price of $5.91 — trading 44.6% below its estimated fair value. The current ROIC % is -45.55%. Allurion Technologies' overall GF Score™ is 16/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROIC % calculated?
ROIC % is calculated from a company's financial statements. For Allurion Technologies (ALURD), the current ROIC % is -45.55% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Allurion Technologies (ALURD) Overvalued in 2026?

Based on GuruFocus' analysis, Allurion Technologies stock appears to be undervalued. The current stock price of $5.91 is trading 44.6% below its estimated GF Value™ of $10.66. GuruFocus considers Allurion Technologies to be Possible Value Trap.

Key valuation signals for ALURD:

  • ROIC %: -45.55%
  • GF Value™: $10.66 vs. price of $5.91 (44.6% below fair value)
  • GF Score™: 16/100 with 4 warning signs

No single metric tells the full story. See the ALURD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Allurion Technologies Business Description

Address 11 Huron Drive, Natick, MA, USA, 01760
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
16GF Score

Get the complete analysis for ALURD

ROIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.91
Price
$10.66
GF Value